Structure Therapeutics (GPCR) Revenue & Revenue Breakdown
Structure Therapeutics Revenue Highlights
00
Structure Therapeutics Revenue by Period
Structure Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | - |
Structure Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $1.33M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | - |
Structure Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
AMLX | Amylyx Pharmaceuticals | $380.79M | $416.00K |
HOOK | HOOKIPA Pharma | $20.13M | - |
MREO | Mereo BioPharma Group | $10.00M | - |
MORF | Morphic | $521.00K | - |
GPCR | Structure Therapeutics | - | - |
XFOR | X4 Pharmaceuticals | - | $560.00K |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
IRON | Disc Medicine | - | - |
DICE | DICE Therapeutics | - | - |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
BMEA | Biomea Fusion | - | - |
TERN | Terns Pharmaceuticals | - | - |
ELDN | Eledon Pharmaceuticals | - | - |